デフォルト表紙
市場調査レポート
商品コード
1409654

オンコロジストの世界市場レポート 2024年

Oncologists Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.94円
オンコロジストの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

オンコロジストの市場規模は近年着実に成長しています。2023年の193億5,000万米ドルから2024年には191億9,000万米ドルへと、CAGR2.3%で拡大します。過去の期間に見られた成長は、がんの罹患率の増加、治療アプローチの進歩、高齢化人口の増加、ヘルスケアインフラの整備、啓蒙・早期発見プログラムの実施などの要因によるものです。

オンコロジストの市場規模は、今後数年間で安定した成長が見込まれます。2028年にはCAGR3.5%で227億2,000万米ドルに成長します。予測期間中に予想される成長は、精密医療や個別化療法の出現、治療法の進歩、腫瘍学における世界の協力関係、疫学の変化や新たな課題、ヘルスケア政策や経済的要因の影響などの要因によるものと考えられます。この時期の主な動向としては、免疫療法の進歩、精密医療の統合、遠隔医療の拡大、データ主導の意思決定へのシフト、共同ケアモデルの採用、患者中心のケアへの注目の高まりなどが挙げられます。

オンコロジスト'市場は、がんの有病率の増加により成長が見込まれています。がんは、少数の体細胞の制御不能な増殖と拡散によって特徴付けられ、その有病率は一定期間中の特定集団内の新規症例数によって決定されます。オンコロジストは、がんの診断と治療を専門とするヘルスケア専門医であり、患者の診察、がんの診断、適切な治療法の特定において重要な役割を果たしています。2021年米国がん協会の報告によると、2020年に新たにがんと診断された患者数は180万人で、以前より大幅に増加しました。国立がん研究センターの報告によると、2020年9月の新規がん罹患者数は43%増の180万6590人でした。したがって、がんの有病率の増加がオンコロジスト'市場の原動力となっています。

高齢化社会の進展は、オンコロジスト'市場の拡大を支える重要な要因です。60歳以上で構成される高齢化社会は、加齢とともにがんのリスクが高まるため、がんにかかりやすくなります。オンコロジストの需要は、高齢者人口におけるがんの有病率の増加とともに上昇します。世界保健機関(WHO)によると、2030年までに世界の6人に1人が60歳以上になるといいます。高齢者の数は2020年には14億人に達し、2050年には2倍以上の21億人に達すると予測されています。したがって、高齢化人口の増加は、予測期間においてオンコロジスト'市場にプラスの影響を与えると予想されます。

2023年のオンコロジスト市場では北米が最大地域でした。オンコロジスト市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 オンコロジスト市場の特徴

第3章 オンコロジストの市場動向と戦略

第4章 オンコロジスト市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のオンコロジスト市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 オンコロジストの市場セグメンテーション

  • 世界のオンコロジスト市場、がんの診断・治療別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • がん診断
  • がん治療
  • 世界のオンコロジスト市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 肺がん
  • 結腸直腸がん
  • 乳がん
  • 肝臓がん
  • 膀胱がん
  • 頭頸部がん
  • 前立腺がん
  • その他
  • 世界のオンコロジスト市場、最終用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 診断研究所
  • 画像診断センター
  • 専門クリニック
  • 学術界
  • その他

第7章 オンコロジスト市場の地域および国分析

  • 世界のオンコロジスト市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のオンコロジスト市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋のオンコロジスト市場

第9章 中国のオンコロジスト市場

第10章 インドのオンコロジスト市場

第11章 日本のオンコロジスト市場

第12章 オーストラリアのオンコロジスト市場

第13章 インドネシアのオンコロジスト市場

第14章 韓国のオンコロジスト市場

第15章 西欧のオンコロジスト市場

第16章 英国のオンコロジスト市場

第17章 ドイツのオンコロジスト市場

第18章 フランスのオンコロジスト市場

第19章 イタリアのオンコロジスト市場

第20章 スペインのオンコロジスト市場

第21章 東欧のオンコロジスト市場

第22章 ロシアのオンコロジスト市場

第23章 北米のオンコロジスト市場

第24章 米国のオンコロジスト市場

第25章 カナダのオンコロジスト市場

第26章 南米のオンコロジスト市場

第27章 ブラジルのオンコロジスト市場

第28章 中東のオンコロジスト市場

第29章 アフリカのオンコロジスト市場

第30章 オンコロジストの市場における競合情勢と企業プロファイル

  • オンコロジスト市場の競合情勢
  • オンコロジスト市場の企業プロファイル
    • Abramson Cancer Center
    • MD Anderson Cancer Center of the University of Texas
    • Lilavati Hospital &Research Centre
    • Mount Elizabeth Hospital
    • Mount Miriam Cancer Hospital

第31章 世界のオンコロジスト市場の競合ベンチマーキング

第32章 世界のオンコロジスト市場の競争力ダッシュボード

第33章 オンコロジスト市場における主要な合併と買収

第34章 オンコロジスト市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11192

“Oncologists Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncologists market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncologists? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The oncologists market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Cancer Diagnostics and Treatment: Cancer Diagnostics; Cancer Treatment
  • 2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head and Neck Cancer; Prostate Cancer; Other Indications
  • 3) By End Use: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia; Other End Uses
  • Companies Mentioned: Abramson Cancer Center; MD Anderson Cancer Center of the University of Texas; Lilavati Hospital & Research Centre; Mount Elizabeth Hospital; Mount Miriam Cancer Hospital
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Oncologists are a specialized type of healthcare practitioner focused on the diagnosis and treatment of cancer. They play a crucial role in evaluating patients, diagnosing cancer, and recommending appropriate treatments, actively participating in the comprehensive care of cancer patients.

The primary areas of focus for oncologists are cancer diagnostics and cancer treatment. Cancer diagnostics involve testing procedures designed to confirm the presence of cancer and identify the specific tumor type. Common cancer types include lung cancer, colorectal cancer, breast cancer, liver cancer, bladder cancer, head and neck cancer, and prostate cancer. Oncologists work in various healthcare settings, including hospitals, diagnostic laboratories, diagnostic imaging centers, specialty clinics, academia, and other related institutions.

The oncologists market research report is one of a series of new reports from The Business Research Company that provides oncologists market statistics, including oncologists industry global market size, regional shares, competitors with an oncologists market share, detailed oncologists market segments, market trends and opportunities, and any further data you may need to thrive in the oncologists industry. This mobile wallet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncologists market size has grown steadily in recent years. It will grow from $19.35 billion in 2023 to $19.19 billion in 2024 at a compound annual growth rate (CAGR) of 2.3%. The growth observed in the historical period can be attributed to factors such as the increasing incidence of cancer, advancements in therapeutic approaches, a growing aging population, development of healthcare infrastructure, and the implementation of awareness and early detection programs.

The oncologists market size is expected to see steady growth in the next few years. It will grow to $22.72 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The anticipated growth in the forecast period can be attributed to factors such as the emergence of precision medicine and personalized therapies, advancements in therapeutic modalities, global collaboration in oncology, shifts in epidemiology and new challenges, as well as influences from healthcare policy and economic factors. Major trends in this period include advancements in immunotherapy, the integration of precision medicine, expansion of telemedicine, a shift towards data-driven decision-making, the adoption of collaborative care models, and an increased focus on patient-centric care.

The oncologists' market is anticipated to experience growth due to the increasing prevalence of cancer. Cancer is characterized by the uncontrolled growth and spread of a few body cells, and its prevalence is determined by the number of new cases within a specific population during a given period. Oncologists, specialized healthcare practitioners focusing on cancer diagnosis and treatment, play a crucial role in examining patients, diagnosing cancer, and identifying suitable treatment options. According to the 2021 American Cancer Society report, there were 1.8 million new cancer cases diagnosed in 2020, reflecting a significant increase from previous years. The National Cancer Institute reported a 43% rise in new cancer cases to 1,806,590 in September 2020. Hence, the growing prevalence of cancer is a driving force behind the oncologists' market.

The growth of the aging population is expected to be a significant factor supporting the expansion of the oncologists' market. An aging population, comprising individuals aged 60 and above, is more susceptible to cancer as the risk of cancer increases with age. The demand for oncologists rises with the growing prevalence of cancer in the elderly population. According to the World Health Organization, by 2030, 1 in 6 people globally will be aged 60 or above. The number of elderly individuals reached 1.4 billion in 2020, and by 2050, it is projected to more than double, reaching 2.1 billion. Therefore, the increasing size of the aging population is expected to have a positive impact on the oncologists' market in the forecast period.

A key trend in the oncologists' market is the focus on new innovations, with major companies developing digital solutions to enhance their positions. For instance, in December 2021, The Roche Group introduced its latest digital solution, the 'Navify Oncology Hub,' designed to simplify clinical workflows and improve decision support for oncology care teams and oncologists. This solution aids in aggregating and organizing patient data across various IT systems within an institution.

Major companies in the oncologists' market are also establishing new collaborative networks to advance research and development efforts. In September 2023, Amgen launched the 'Amgen Partners of Choice' network, bringing together its oncology research and development experts with clinical leaders at eight global research centers. The network, part of Amgen's mission to enhance care through partnerships, fosters academic collaboration to advance innovative treatment options for patients with significant unmet needs.

In April 2021, Siemens Healthineers AG acquired Varian Medical Systems, Inc. for an undisclosed amount, enhancing resources to support cancer patients across major clinical pathways. The acquisition aims to address the rising rates of cancer by providing personalized, data-driven diagnosis and cancer care. Varian Medical Systems, Inc., a US-based company, is a provider of radiation oncology software and treatments.

Major companies operating in the oncologists market report are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charite - Universitatsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., Aegerion Pharmaceuticals Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Celgene Corporation, Gilead Sciences Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc

North America was the largest region in the oncologists market in 2023. The regions covered in the oncologists market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oncologists market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oncologists market includes revenues earned by entities by providing diagnoses and treats cancer, radiation oncologists and surgical oncologists. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Oncologists Market Characteristics

3. Oncologists Market Trends And Strategies

4. Oncologists Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Oncologists Market Size and Growth

  • 5.1. Global Oncologists Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Oncologists Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Oncologists Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oncologists Market Segmentation

  • 6.1. Global Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer Diagnostics
  • Cancer Treatment
  • 6.2. Global Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lungs Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Liver Cancer
  • Bladder Cancer
  • Head and Neck Cancer
  • Prostate Cancer
  • Other Indications
  • 6.3. Global Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Diagnostic Imaging Centers
  • Specialty Clinics
  • Academia
  • Other End Uses

7. Oncologists Market Regional And Country Analysis

  • 7.1. Global Oncologists Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Oncologists Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oncologists Market

  • 8.1. Asia-Pacific Oncologists Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oncologists Market

  • 9.1. China Oncologists Market Overview
  • 9.2. China Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oncologists Market

  • 10.1. India Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oncologists Market

  • 11.1. Japan Oncologists Market Overview
  • 11.2. Japan Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oncologists Market

  • 12.1. Australia Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oncologists Market

  • 13.1. Indonesia Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oncologists Market

  • 14.1. South Korea Oncologists Market Overview
  • 14.2. South Korea Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oncologists Market

  • 15.1. Western Europe Oncologists Market Overview
  • 15.2. Western Europe Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oncologists Market

  • 16.1. UK Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oncologists Market

  • 17.1. Germany Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oncologists Market

  • 18.1. France Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oncologists Market

  • 19.1. Italy Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oncologists Market

  • 20.1. Spain Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oncologists Market

  • 21.1. Eastern Europe Oncologists Market Overview
  • 21.2. Eastern Europe Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oncologists Market

  • 22.1. Russia Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oncologists Market

  • 23.1. North America Oncologists Market Overview
  • 23.2. North America Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oncologists Market

  • 24.1. USA Oncologists Market Overview
  • 24.2. USA Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oncologists Market

  • 25.1. Canada Oncologists Market Overview
  • 25.2. Canada Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oncologists Market

  • 26.1. South America Oncologists Market Overview
  • 26.2. South America Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oncologists Market

  • 27.1. Brazil Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oncologists Market

  • 28.1. Middle East Oncologists Market Overview
  • 28.2. Middle East Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oncologists Market

  • 29.1. Africa Oncologists Market Overview
  • 29.2. Africa Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Oncologists Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Oncologists Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oncologists Market Competitive Landscape And Company Profiles

  • 30.1. Oncologists Market Competitive Landscape
  • 30.2. Oncologists Market Company Profiles
    • 30.2.1. Abramson Cancer Center
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. MD Anderson Cancer Center of the University of Texas
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Lilavati Hospital & Research Centre
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Mount Elizabeth Hospital
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Mount Miriam Cancer Hospital
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Oncologists Market Competitive Benchmarking

32. Global Oncologists Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Oncologists Market

34. Oncologists Market Future Outlook and Potential Analysis

  • 34.1 Oncologists Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Oncologists Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Oncologists Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer